Rocket Pharmaceuticals, Inc.
RCKT· Nasdaq
Released Nov 12, 2015, before the open
10-Q filed Nov 12, 2015, 43 days after period end · 0001193125-15-374713
| Metric | Q3 2015 | Q3 2014 |
|---|---|---|
| Net Income | -$55.96M | -$2.39M |
| EPS Diluted | -$2.48 | -$3.42 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rocket Pharmaceuticals, Inc. · CIK 1281895 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 12, 2015 · 43 d after period end